Huang, n. L., Zhang, n. Y., Liu, n. P., Lan, n. L., Yang, n. L., Wang, n. B., . . . Qin, n. X. (2025). Author response for 'Design, synthesis and biological evaluation of 2H-[1,4]oxazino-[2,3-f]quinazolin derivatives as potential EGFR inhibitors for Non-small cell lung cancer'. https://doi.org/10.1039/d4md01016g/v2/response1
Chicago-Zitierstil (17. Ausg.)Huang, null Linchang, null Ying Zhang, null Peng Liu, null Lihong Lan, null Lifang Yang, null Bo Wang, null Tingting Cao, null Liming Hu, und null Xuemei Qin. Author Response for 'Design, Synthesis and Biological Evaluation of 2H-[1,4]oxazino-[2,3-f]quinazolin Derivatives as Potential EGFR Inhibitors for Non-small Cell Lung Cancer'. 2025. https://doi.org/10.1039/d4md01016g/v2/response1.
MLA-Zitierstil (9. Ausg.)Huang, null Linchang, et al. Author Response for 'Design, Synthesis and Biological Evaluation of 2H-[1,4]oxazino-[2,3-f]quinazolin Derivatives as Potential EGFR Inhibitors for Non-small Cell Lung Cancer'. 2025. https://doi.org/10.1039/d4md01016g/v2/response1.